Stock Detail
Videos
Dyadic Applied BioSolutions (DYAI) Company Webcast
Dyadic Applied BioSolutions (NASDAQ: DYAI) is focused on leveraging advanced microbial and protein expression technologies to support the development and manufacture of biopharmaceuticals, vaccines, and other biologic products. The company's proprietary technology...
Dyadic Applied BioSolutions (DYAI) Fireside Chat
Dyadic Applied BioSolutions (Nasdaq: DYAI) is a global biotechnology company that uses its proprietary microbial platforms to produce recombinant proteins that are sold or licensed to partners across the life sciences, food and nutrition, and bio-industrial markets....
Dyadic International (DYAI) Fireside Chat
For this fireside chat, we welcome Dyadic, Inc., which trades on the NASDAQ under the ticker DYAI. Joining us from the company is Mark Emalfarb, Chief Executive Officer. Dyadic International, Inc. (NASDAQ: DYAI) is a global biotechnology company focused on building...
News
Dyadic Announces Continued Listing on the Nasdaq Capital Market
JUPITER, Fla., July 24, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (Nasdaq: DYAI) ("Dyadic" or the "Company"), d/b/a Dyadic Applied BioSolutions, a biotechnology company developing recombinant protein solutions across the life sciences, food and nutrition,...
Dyadic Expands Bio industrial Pipeline with New Proprietary Industrial Enzyme Program
New initiative builds on EN3ZYME™ launch and highlights scalability of the Dapibus™ platformJUPITER, Fla., July 16, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (Nasdaq: DYAI) ("Dyadic" or the "Company"), d/b/a Dyadic Applied BioSolutions, a...
Global Collaborations Continue to Validate Dyadic’s C1 Platform and Expands Commercial Potential
C1 Monoclonal Antibody Progress for RSV and Malaria Following Full $3.1 Million Gates Foundation Grant FundingJUPITER, Fla., July 07, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (Nasdaq: DYAI) ("Dyadic" or the "Company"), d/b/a Dyadic Applied BioSolutions, a...